ORTX
Price:
$16.7
Market Cap:
$380.11M
Orchard Therapeutics plc is a biopharmaceutical firm dedicated to developing gene-based treatments for severe and often fatal rare conditions, operating across the United Kingdom, European Union, and the United States. Their innovative gene therapy strategy involves modifying a patient's own hematopoietic stem cells, converting them into a therapeutic cellular drug that can address the illness with just one dose. The company markets Strimvelis, a gammaretroviral therapy approved for treating adenosine deaminase-severe combined immunodeficiency (ADA-SCID). Orchard's clinical pipeline features several investigational therapies, including OTL-101 for ADA-SCID, OTL-200 targeting metachromatic le...[Read more]
Industry
Biotechnology
IPO Date
2018-10-31
Stock Exchange
NASDAQ
Ticker
ORTX
According to Orchard Therapeutics plc’s latest financial reports and current stock price. The company's current Enterprise Value is 369.77M. This represents a change of 254.88% compared to the average of 104.20M of the last 4 quarters.
The mean historical Enterprise Value of Orchard Therapeutics plc over the last ten years is 307.73M. The current 369.77M Enterprise Value has changed 11.92% with respect to the historical average. Over the past ten years (40 quarters), ORTX's Enterprise Value was at its highest in in the December 2019 quarter at 1.38B. The Enterprise Value was at its lowest in in the December 2017 quarter at -89856000.00.
Average
307.73M
Median
137.85M
Minimum
19.02M
Maximum
1.31B
Discovering the peaks and valleys of Orchard Therapeutics plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 6.78%
Maximum Annual Enterprise Value = 1.31B
Minimum Annual Increase = -77.86%
Minimum Annual Enterprise Value = 19.02M
| Year | Enterprise Value | Change |
|---|---|---|
| 2022 | 37.02M | -77.86% |
| 2021 | 167.21M | -61.35% |
| 2020 | 432.64M | -66.95% |
| 2019 | 1.31B | 6.78% |
| 2018 | 19.02M | -63.07% |
| 2017 | 51.49M | -62.65% |
The current Enterprise Value of Orchard Therapeutics plc (ORTX) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
212.29M
5-year avg
392.96M
10-year avg
307.73M
Orchard Therapeutics plc’s Enterprise Value is greater than Vigil Neuroscience, Inc. (346.93M), greater than Checkpoint Therapeutics, Inc. (334.68M), less than Revance Therapeutics, Inc. (722.13M), less than G1 Therapeutics, Inc. (402.64M), less than Climb Bio, Inc. (772.15M), greater than Y-mAbs Therapeutics, Inc. (332.06M), greater than scPharmaceuticals Inc. (313.84M), greater than iTeos Therapeutics, Inc. (245.99M), greater than SomaLogic, Inc. (-23127083.00), less than Claritev Corporation (5.11B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 346.93M | $375.71M | |
| 334.68M | $367.72M | |
| 722.13M | $381.02M | |
| 402.64M | $377.75M | |
| 772.15M | $780.03M | |
| 332.06M | $391.22M | |
| 313.84M | $302.20M | |
| 245.99M | $448.68M | |
| -23127083.00 | $396.23M | |
| 5.11B | $526.61M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Orchard Therapeutics plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Orchard Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Orchard Therapeutics plc's Enterprise Value?
What is the highest Enterprise Value for Orchard Therapeutics plc (ORTX)?
What is the 3-year average Enterprise Value for Orchard Therapeutics plc (ORTX)?
What is the 5-year average Enterprise Value for Orchard Therapeutics plc (ORTX)?
How does the current Enterprise Value for Orchard Therapeutics plc (ORTX) compare to its historical average?